1. Home
  2. SLDP vs TNDM Comparison

SLDP vs TNDM Comparison

Compare SLDP & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Power Inc.

SLDP

Solid Power Inc.

HOLD

Current Price

$5.31

Market Cap

993.3M

Sector

Energy

ML Signal

HOLD

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

HOLD

Current Price

$20.87

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDP
TNDM
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
993.3M
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SLDP
TNDM
Price
$5.31
$20.87
Analyst Decision
Strong Buy
Buy
Analyst Count
1
16
Target Price
$7.00
$22.00
AVG Volume (30 Days)
10.0M
2.6M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,802,000.00
$1,007,001,000.00
Revenue This Year
$27.38
$8.59
Revenue Next Year
$36.18
$10.19
P/E Ratio
N/A
N/A
Revenue Growth
9.85
17.87
52 Week Low
$0.68
$9.98
52 Week High
$8.86
$38.28

Technical Indicators

Market Signals
Indicator
SLDP
TNDM
Relative Strength Index (RSI) 47.16 64.34
Support Level $4.78 $19.47
Resistance Level $5.33 $21.07
Average True Range (ATR) 0.37 1.15
MACD -0.04 -0.08
Stochastic Oscillator 42.77 69.86

Price Performance

Historical Comparison
SLDP
TNDM

About SLDP Solid Power Inc.

Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: